Kindred Biosciences reported $79.77M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adma Biologics ADMA:US $ 102.78M 8.81M
Bayer BAYN:GR € 31103M 714M
Biocryst Pharmaceuticals BCRX:US $ -147.04M 40.97M
Dynavax Technologies DVAX:US $ 67.58M 15.8M
Eli Lilly And LLY:US $ 7757M 1312.6M
Idexx Laboratories IDXX:US $ 754.75M 7.29M
JAZZ PHA JAZZ:US $ 3938.48M 193.01M
Kindred Biosciences KIN:US $ 79.77M 4.02M
Minerva Neurosciences NERV:US $ 28.08M 8.09M
Novavax NVAX:US $ 461.34M 284.23M
Phibro Animal Health PAHC:US $ 233.3M 5.22M
Zoetis ZTS:US $ 4679M 329M